Stay updated on APL-2 in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now lists revision: v3.3.2 in the study documents area, replacing v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T11:13:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page; the record now presents only the study details and related information.
    Difference
    0.4%
    Check dated 2025-11-18T06:58:50.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content remains the same with only cosmetic layout updates.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:29.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Added a prominent operating-status notice and a link to cc.nih.gov/opm.gov for updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T05:23:15.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:02:26.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Update: Revision changed from v3.0.1 to v3.0.2; removal of the Back to Top element. No other substantive content changes noted.
    Difference
    0.3%
    Check dated 2025-09-14T19:02:54.000Z thumbnail image

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.